AUPH
Aurinia Pharmaceuticals Inc
16.40$
-1.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 66.7% | 50.0% | 75.4% | 19.4% | 5.8% | 19.0% | 125.9% | 175.0% | 17.0% | 45.0% | 54.6% | 14.2% | 1.5% | 20.0% | 0.8% | 0.1% | 13.3% | 5.1% | 2.3% | 0.2% | 8,937.8% | 16,624.5% | 100.4% | 2.4% | 4.2% | 8.1% | 12.0% | 11.5% | |
| 33.3% | 50.0% | 24.6% | 80.6% | 94.2% | 100.0% | 100.0% | 100.0% | 83.0% | 55.0% | 45.4% | 85.8% | 98.5% | 80.0% | 99.2% | 99.9% | 86.7% | 94.9% | 97.7% | 99.8% | -8,837.8% | 100.0% | 100.0% | 97.6% | 95.8% | 91.9% | 88.0% | 88.5% | |
| 183.3% | 105.0% | 529.3% | 158.8% | 59.6% | 119.1% | 1,061.6% | 1,650.9% | 539.5% | 1,272.0% | 295.2% | 188.8% | 116.6% | 374.8% | 89.5% | 203.9% | 3,277.7% | 6,800.9% | 8,401.2% | 8,078.6% | 8,937.8% | 16,624.5% | 100.4% | 112.1% | 33.6% | 28.3% | 8.8% | 11.5% | |
| 175.0% | 75.0% | 196.4% | 57.6% | 41.7% | 108.8% | 616.4% | 830.6% | 175.8% | 244.6% | 117.1% | 89.1% | 95.5% | 295.9% | 63.4% | 235.2% | 2,478.4% | 2,665.1% | 4,028.9% | 2,880.0% | 2,953.3% | 7,024.5% | 194.1% | 375.9% | 146.5% | 111.1% | 67.2% | 34.8% | |
| 375.0% | 140.0% | 771.2% | 222.8% | 107.2% | 246.4% | 1,918.4% | 2,671.5% | 768.7% | 1,598.1% | 448.3% | 308.3% | 246.0% | 774.2% | 188.1% | 524.9% | 6,303.2% | 10,128.9% | 13,285.0% | 11,305.2% | 12,229.2% | 28,698.4% | 308.1% | 493.9% | 178.9% | 144.2% | 90.0% | 51.4% | |
| -341.7% | -90.0% | -746.6% | -142.1% | -12.9% | -146.4% | -1,818.4% | -2,571.5% | -685.7% | -1,543.0% | -422.0% | -247.9% | -147.5% | -694.2% | -88.8% | -580.4% | -6,216.5% | -10,034.0% | -13,187.3% | -11,205.5% | -12,129.2% | -28,598.4% | -208.1% | -396.3% | -83.2% | -52.2% | -2.0% | 37.1% | |
| 0.0% | 0.0% | 1.7% | 0.0% | 0.0% | 0.5% | 0.0% | 32.4% | 7.6% | 6.1% | 21.8% | 25.4% | 0.4% | 0.1% | 1.6% | 10.9% | 10.8% | 21.3% | 15.6% | 167.1% | 482.5% | 12.3% | 10.6% | 1.2% | 3.8% | 1.6% | 2.1% | 1.5% | |
| -300.0% | – | -694.7% | -138.7% | -2.5% | -189.5% | -1,771.1% | -2,468.3% | -648.8% | -1,448.7% | -409.7% | -187.5% | -159.6% | -259.6% | -158.1% | -675.0% | -5,988.1% | -7,917.9% | -13,465.3% | -16,855.2% | -13,833.0% | -27,748.7% | -205.1% | -395.1% | -79.3% | -44.1% | 3.2% | 40.3% | |
| -16.7% | 0.0% | 1.5% | 1.0% | 0.6% | 1.7% | 0.3% | 0.1% | 0.0% | 15.0% | 19.1% | 25.4% | 3.0% | 433.8% | 0.9% | -406.5% | 10.8% | -2,116.2% | 278.0% | 5,696.2% | 15.8% | 45.3% | -0.2% | 1.7% | 1.4% | 0.3% | 0.7% | -61.1% | |
| -283.3% | -90.0% | -696.2% | -139.8% | -3.1% | -191.2% | -1,771.4% | -2,468.4% | -648.7% | -1,448.7% | -409.7% | -187.5% | -107.0% | -259.6% | -158.1% | -268.4% | -5,988.1% | -7,917.9% | -13,465.3% | -16,855.2% | -13,848.8% | -27,794.0% | -204.9% | -396.8% | -80.7% | -44.5% | 2.4% | 101.5% | |
| -250.0% | -80.0% | -701.1% | -135.9% | -7.2% | -128.3% | -1,635.7% | -2,390.1% | -641.6% | -1,461.5% | -366.7% | -128.4% | -124.7% | -182.5% | -145.1% | -617.5% | -5,646.0% | -9,371.1% | -12,332.4% | -10,859.0% | -11,647.3% | -28,230.2% | -205.4% | -389.1% | -81.1% | -35.9% | 13.5% | 45.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.